Cargando…
Regulatory de novo mutations underlying intellectual disability
The genetic aetiology of a major fraction of patients with intellectual disability (ID) remains unknown. De novo mutations (DNMs) in protein-coding genes explain up to 40% of cases, but the potential role of regulatory DNMs is still poorly understood. We sequenced 63 whole genomes from 21 ID proband...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978454/ https://www.ncbi.nlm.nih.gov/pubmed/36854624 http://dx.doi.org/10.26508/lsa.202201843 |
_version_ | 1784899524287791104 |
---|---|
author | De Vas, Matias G Boulet, Fanny Joshi, Shweta S Garstang, Myles G Khan, Tahir N Atla, Goutham Parry, David Moore, David Cebola, Inês Zhang, Shuchen Cui, Wei Lampe, Anne K Lam, Wayne W Ferrer, Jorge Pradeepa, Madapura M Atanur, Santosh S |
author_facet | De Vas, Matias G Boulet, Fanny Joshi, Shweta S Garstang, Myles G Khan, Tahir N Atla, Goutham Parry, David Moore, David Cebola, Inês Zhang, Shuchen Cui, Wei Lampe, Anne K Lam, Wayne W Ferrer, Jorge Pradeepa, Madapura M Atanur, Santosh S |
author_sort | De Vas, Matias G |
collection | PubMed |
description | The genetic aetiology of a major fraction of patients with intellectual disability (ID) remains unknown. De novo mutations (DNMs) in protein-coding genes explain up to 40% of cases, but the potential role of regulatory DNMs is still poorly understood. We sequenced 63 whole genomes from 21 ID probands and their unaffected parents. In addition, we analysed 30 previously sequenced genomes from exome-negative ID probands. We found that regulatory DNMs were selectively enriched in fetal brain-specific enhancers as compared with adult brain enhancers. DNM-containing enhancers were associated with genes that show preferential expression in the prefrontal cortex. Furthermore, we identified recurrently mutated enhancer clusters that regulate genes involved in nervous system development (CSMD1, OLFM1, and POU3F3). Most of the DNMs from ID probands showed allele-specific enhancer activity when tested using luciferase assay. Using CRISPR-mediated mutation and editing of epigenomic marks, we show that DNMs at regulatory elements affect the expression of putative target genes. Our results, therefore, provide new evidence to indicate that DNMs in fetal brain-specific enhancers play an essential role in the aetiology of ID. |
format | Online Article Text |
id | pubmed-9978454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-99784542023-03-03 Regulatory de novo mutations underlying intellectual disability De Vas, Matias G Boulet, Fanny Joshi, Shweta S Garstang, Myles G Khan, Tahir N Atla, Goutham Parry, David Moore, David Cebola, Inês Zhang, Shuchen Cui, Wei Lampe, Anne K Lam, Wayne W Ferrer, Jorge Pradeepa, Madapura M Atanur, Santosh S Life Sci Alliance Research Articles The genetic aetiology of a major fraction of patients with intellectual disability (ID) remains unknown. De novo mutations (DNMs) in protein-coding genes explain up to 40% of cases, but the potential role of regulatory DNMs is still poorly understood. We sequenced 63 whole genomes from 21 ID probands and their unaffected parents. In addition, we analysed 30 previously sequenced genomes from exome-negative ID probands. We found that regulatory DNMs were selectively enriched in fetal brain-specific enhancers as compared with adult brain enhancers. DNM-containing enhancers were associated with genes that show preferential expression in the prefrontal cortex. Furthermore, we identified recurrently mutated enhancer clusters that regulate genes involved in nervous system development (CSMD1, OLFM1, and POU3F3). Most of the DNMs from ID probands showed allele-specific enhancer activity when tested using luciferase assay. Using CRISPR-mediated mutation and editing of epigenomic marks, we show that DNMs at regulatory elements affect the expression of putative target genes. Our results, therefore, provide new evidence to indicate that DNMs in fetal brain-specific enhancers play an essential role in the aetiology of ID. Life Science Alliance LLC 2023-02-28 /pmc/articles/PMC9978454/ /pubmed/36854624 http://dx.doi.org/10.26508/lsa.202201843 Text en © 2023 De Vas et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles De Vas, Matias G Boulet, Fanny Joshi, Shweta S Garstang, Myles G Khan, Tahir N Atla, Goutham Parry, David Moore, David Cebola, Inês Zhang, Shuchen Cui, Wei Lampe, Anne K Lam, Wayne W Ferrer, Jorge Pradeepa, Madapura M Atanur, Santosh S Regulatory de novo mutations underlying intellectual disability |
title | Regulatory de novo mutations underlying intellectual disability |
title_full | Regulatory de novo mutations underlying intellectual disability |
title_fullStr | Regulatory de novo mutations underlying intellectual disability |
title_full_unstemmed | Regulatory de novo mutations underlying intellectual disability |
title_short | Regulatory de novo mutations underlying intellectual disability |
title_sort | regulatory de novo mutations underlying intellectual disability |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978454/ https://www.ncbi.nlm.nih.gov/pubmed/36854624 http://dx.doi.org/10.26508/lsa.202201843 |
work_keys_str_mv | AT devasmatiasg regulatorydenovomutationsunderlyingintellectualdisability AT bouletfanny regulatorydenovomutationsunderlyingintellectualdisability AT joshishwetas regulatorydenovomutationsunderlyingintellectualdisability AT garstangmylesg regulatorydenovomutationsunderlyingintellectualdisability AT khantahirn regulatorydenovomutationsunderlyingintellectualdisability AT atlagoutham regulatorydenovomutationsunderlyingintellectualdisability AT parrydavid regulatorydenovomutationsunderlyingintellectualdisability AT mooredavid regulatorydenovomutationsunderlyingintellectualdisability AT cebolaines regulatorydenovomutationsunderlyingintellectualdisability AT zhangshuchen regulatorydenovomutationsunderlyingintellectualdisability AT cuiwei regulatorydenovomutationsunderlyingintellectualdisability AT lampeannek regulatorydenovomutationsunderlyingintellectualdisability AT lamwaynew regulatorydenovomutationsunderlyingintellectualdisability AT regulatorydenovomutationsunderlyingintellectualdisability AT ferrerjorge regulatorydenovomutationsunderlyingintellectualdisability AT pradeepamadapuram regulatorydenovomutationsunderlyingintellectualdisability AT atanursantoshs regulatorydenovomutationsunderlyingintellectualdisability |